InvestLog
RAPP logo

RAPP

Rapport Therapeutics, Inc. Common StockNASDAQHealthcare
$33.58-3.57%ClosedMarket Cap: $1.23B

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

7

Sales

16

Buy/Sell Ratio

0.44

Total Bought

$0.00

Total Sold

$15.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Mar 31Gault Cherylofficer: Chief Operating OfficerSell2,839$28.55159,914
Tue Mar 31Gault Cherylofficer: Chief Operating OfficerSell7,161$28.04162,753
Thu Mar 26Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell10,115$29.99286,876
Mon Mar 09Gault Cherylofficer: Chief Operating OfficerSell2,014$28.93169,914
Thu Feb 19Ceesay Abrahamdirector, officer: Chief Executive OfficerSell2,100$29.8020,729
Thu Feb 19Bredt Davidofficer: Chief Scientific OfficerSell900$28.02394,675
Thu Feb 19Bredt Davidofficer: Chief Scientific OfficerSell6,000$1.80393,075
Thu Feb 19Bredt Davidofficer: Chief Scientific OfficerSell5,400$28.95389,275
Thu Feb 19Bredt Davidofficer: Chief Scientific OfficerSell2,200$29.59387,075
Thu Feb 19Ceesay Abrahamdirector, officer: Chief Executive OfficerSell2,983$29.0422,829
Thu Feb 19Ceesay Abrahamdirector, officer: Chief Executive OfficerSell2,281$29.80556,247
Thu Feb 19Ceesay Abrahamdirector, officer: Chief Executive OfficerSell3,552$29.05558,528